Delivery Order SPE2DB20D3505-SPE2DB25FV0V1
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,486 delivery order on July 24, 2025, for Enbrel 25 mg/0.5 mL syringes under a firm fixed price contract type with no set-aside designation. The order, designated as a child contract action, is set for completion by July 25, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $9,158.68 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Enbrel 50 mg/ml syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a near-term pharmaceutical supply requirement within the military healthcare supply chain. This award is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml syringes valued at $9,949.47 on July 21, 2025, with completion anticipated by July 22, 2025. This competitive, non-set-aside award utilizes firm fixed pricing under a delivery order contract type and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency has awarded a delivery order valued at $8,576.63 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $23,640.57 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick prefilled syringes on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,168.81 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml syringes, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. The contract represents a continuation of pharmaceutical supply delivery under AmerisourceBergen's broader federal contracting...
- The Defense Logistics Agency awarded a $13,844.92 delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's established role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order valued at $13,729.56 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. The delivery order is set to be completed by July 31, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within a...
- The Defense Logistics Agency awarded a delivery order valued at $9,253.56 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of Enbrel 50 mg/ml syringes. The contract has a ceiling value of $16,608.56 and a performance period running through August 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FV0V1Delivery Order
The Defense Logistics Agency awarded a $6,012.52 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL syringes, with performance in Conshohocken, Pennsylvania and completion by July 31, 2025. This non-set-aside, firm fixed-price contract represents a competitively awarded delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The award reflects the company's established role as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is a child contract under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. As a leading pharmaceutical distributor, AmerisourceBergen maintains a significant portfolio of federal medical supply contracts with DLA and other government health agencies, demonstrating substantial capability to fulfill specialized pharmaceutical needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 7/30/25 |